In the media: Genomeweb: Partial reimbursement for comprehensive DNA test in the Netherlands
This week, Genomeweb’s Precision Oncology News brought the news that the Dutch House of Representatives has recently unanimously decided to reimburse the comprehensive DNA testing for certain patient groups.
Read the article.
More information about the comprehensive DNA test.
You read an article in the category Billing code. You may also be interested in OncoAct.All news
Also read
Nature publication: High resolution DNA-image of metastatic tumor provides new treatment insights
For the first time, Dutch researchers have created a detailed overview of the landscape of DNA-deviations in thousands of metastatic …
Without structured real world data, it remains guesswork who truly benefits
The decision by the Dutch National Health Care Institute (Zorginstituut Nederland, ZiNL) to reassess the reimbursement of expensive medicines after …
Healthcare providers share insights about GENAYA for young adult cancer patients
In a series of short videos, our specialists share their insights on the GENAYA project. They explain what GENAYA is, …
If the practitioner doesn’t know where the primary tumor is located, they cannot offer a targeted treatment plan, and nor can they give the patient an estimate of their life expectancy.